Management Team

Víctor Cervera-Carrascón

PhD, VP Scientific Affairs and External Strategy

Víctor Cervera-Carrascón serves as Vice President (Scientific Affairs and External Strategy), bringing a unique combination of scientific expertise and strategic insight to the interaction with key external parties. With a focus on immunotherapy and the development of oncolytic viruses to enhance T-cell responses and immune checkpoint blockade, Victor plays a pivotal role in advancing the company’s mission.

In his capacity, Victor holds key business development functions focused on strategic partnerships. Leveraging his scientific background, he works towards seamless integration of innovative approaches into business strategies.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Aino Kalervo

MSc, MS, Chief Operating Officer

John Goldfinch

MBA, CRM, US Clinical Lead & CEO - TILT Biotherapeutics LLC

Suvi Sorsa

PhD, VP Clinical Affairs

Hanna Kirk

MSc, VP Product Development

Riikka Havunen

PhD, VP Operations